Lack of association between TNF-308 polymorphism and the clinical and immunological characteristics of systemic lupus erythematosus and primary Sjögren's syndrome

Clinical and Experimental Rheumatology

Volumn 23, Issue 3, 2005, Pages 339-344

  Tobón, Gabriel J ^a   Correa, Paula A ^a,b   Gomez, Luis M ^a   Anaya, Juan Manuel ^a  

^a UNIVERSIDAD DEL ROSARIO   (Colombia)

^b UNIVERSIDAD PONTIFICIA BOLIVARIANA   (Colombia)

Author keywords

Polymorphism; Primary Sj gren's syndrome; Systemic lupus erythematosus; Tumor necrosis factor

Indexed keywords

AUTOANTIBODY; TUMOR NECROSIS FACTOR;

ADULT; ALLELE; ARTICLE; BLOOD SAMPLING; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; ENVIRONMENTAL FACTOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC ANALYSIS; HUMAN; IMMUNE RESPONSE; IMMUNOLOGY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEALTH STATUS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; SJOGREN'S SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 20444455423     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. HAJEER AH, HUTCHINSON IV: Influence of TNFα gene polymorphisms on TNFα production and disease. Hum Immunol 2001; 62: 1191-9.
2. McDERMOTT MF: TNF and TNFR biology in health and disease. Cell Mol Biol 2001; 47: 619-35.
3. GOMEZ D, CORREA PA, CADENA J, GÓMEZ LM, MOLINA JF, ANAYA JM: Th1/Th2 Cytokines in systemic lupus erythematosus. Is TNF-α protective ? Semin Arthritis Rheum 2004; 33: 404-13.
4. FOX RI, KANG HI, ANDO D, ABRAMS J, PISA E: Cytokine mRNA expression in salivary gland biopsies of Sjögren's syndrome. J Immunol 1994; 152: 5532-9.
5. CARDON LR, BELL J: Association study designs for complex diseases. Nature Rev 2001; 2: 91-9.
6. BAENA A, LEUNG JY, SULLIVAN AD et al.: TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry. Genes Immun 2002; 3: 482-7.
7. CORREA PA, GOMEZ LM, CADENA J, ANAYA JM: Tumor necrosis factor alpha polymorphism in autoimmune rheumatic diseases and tuberculosis. J Rheumatol 2005; 32: 219-24.
8. CLANCY RM, BACKER CB, YIN X, KAPUR RP, MOLAD Y, BUYON JP: Cytokine polymorphisms and histologic expression in autopsy studies: contribution of TNF-alpha and TGF-beta 1 to the pathogenesis of autoimmune-associated congenital heart block. J Immunol 2003; 171: 3253-61.
9. MAY LA, HUANG Q, MORRIS D, DANIS V, MANOLIOS N: Relationship of tumour necrosis factor alpha gene polymorphisms and neuropsychiatric lupus. Lupus 2002; 11: 114-8.
10. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
11. VITALI C, BOMBARDIERI S, JONSSON R et al.: Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002; 61: 554-8.
12. WILSON AG, SYMONS JA, McDOWELL T, DUFF GW: Single base change in the human tumor necrosis factor alpha (TNFα) gene detectable by NcoI restriction of the PCR product. Hum Mol Genet 1992; 1: 353.
13. OXHOLM P, ASMUSSEN K, AXÉLL T et al.: Sjögren's syndrome: terminology. Clin Exp Rheumatol 1995; 13: 693-6.
14. BOMBARDIER C, GLADMAN DD, UROWITZ MB, CARON D, CHANG CH: Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 1992; 35: 630-40.
15. STOLL T, SEIFERT B, ISENBERG DA: SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br J Rheumatol 1996; 35: 248-54.
16. CARVAJAL-CARMONA LG, SOTO ID, PINEDA N et al.: Strong Amerind/white sex bias and a possible Sephardic contribution among the founders of a population in northwest Colombia. Am J Hum Genet 2000; 67: 1287-95.
17. CORREA PA, WHITWORTH WC, KUFFNER T, McNICHOLL J, ANAYA JM: HLA-DR and DQB1 gene polymorphism in the North-western Colombian population. Tissue Antigens 2002; 59: 436-9.
18. Van der LINDEN MW, van der SLIK AR, ZANELLI E et al.: Six microsatellite markers on the short arm of chromosome 6 in relation to HLA-DR3 and TNF-308A in systemic lupus erythematosus. Genes Immun 2001; 2: 373-80.
19. ZUNIGA J, VARGAS-ALARÓN G, HERNANDEZ-PACHECO G, PORTAL-CELHAY C, YAMAMOTO-FURUSHO JK, GRANADOS J: Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with systemic lupus erythematosus. Genes Immun 2001; 2: 363-6.
20. TSUCHIYA N, KAWASAKI A, TSAO BP, KOMATA T, GROSSMAN JM, TOKUNAGA K: Analysis of the association of HLA-DRB1, TNF alpha promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test. Genes Immun 2001; 2: 317-22.
21. WERTH VP, ZHANG W, DORTZBACH K, SULLIVAN K: Association of a promoter polymorphism of tumor necrosis factor-alpha with subacute cutaneous lupus erythematosus and distinct photoregulation of transcription. J Invest Dermatol 2000; 115: 726-30.
22. ROOD MJ, van KRUGTEN MV, ZANELLI E et al.: TNF-308A and HLA-DR3 alleles contribute independently to susceptibility to systemic lupus erythematosus. Arthritis Rheum 2000; 43: 129-34.
23. SULLIVAN KE, WOOTEN C, SCHMECKPEPER BJ, GOLDMAN D, PETRI MA: A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum 1997; 40: 2207-11.
24. LU LY, DING WZ, FICI D et al.: Molecular analysis of major histocompaltibility complex allelic associations with systemic lupus erythematosus in Taiwan. Arthritis Rheum 1997; 40: 1138-45.
25. HAJEER AH, WORTHINGTON J, DAVIES EJ, HILLARBY MC, POULTON K, OLLIER WE: TNF microsatellite a2, b3 and d2 alleles are associated with systemic lupus erythematosus. Tissue Antigens 1997; 49: 222-7.
26. CHEN CJ, YEN JH, TSAI WC et al.: The TNF2 allele does not contribute towards susceptibility to systemic lupus erythematosus. Immunol Lett 1997; 55: 1-3.
27. RUDWALEIT M, TIKLY M, KHAMASHTA M et al.: Interethnic differences in the association of tumor necrosis factor promoter polymorphisms with systemic lupus erythematosus. J Rheumatol 1996; 23: 1725-8.
28. FONG KY, HOWE HS, TIN SK, BOEY ML, FENG PH: Polymorphism of the regulatory region of tumour necrosis factor alpha gene in patients with systemic lupus erythematosus. Ann Acad Med Singapore 1996; 25: 90-3.
29. DANIS VA, MILLINGTON M, HYLAND V, LAWFORD R, HUANG Q, GRENNAN D: Increased frequency of the uncommon allele of a tumour necrosis factor alpha gene polymorphism in rheumatoid arthritis and systemic lupus erythematosus. Dis Markers 1994; 12: 127-33.
30. WILSON AG, GORDON C, di GIOVINE FS et al.: A genetic association between systemic lupus erythematosus and tumor necrosis factor alpha. Eur J Immunol 1994; 24:191-5.
31. TOMITA Y, HASHIMOTO S, YAMAGAMI K, SAWADA S, HORIE T: Restriction fragment length polymorphism (RFLP) analysis in the TNF genes of patients with systemic lupus erythematosus (SLE). Clin Exp Rheumatol 1993; 11: 533-6.
32. HUIZINGA TW, WESTENDORP RG, BOLLEN EL et al.: TNF-alpha promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 1997; 72: 149-53.
33. MYCKO M, KOWALSKI W, KWINKOWSKI M et al.: Multiple sclerosis: the frequency of allelic forms of tumor necrosis factor and lymphotoxin-alpha. J Neuroimmunol 1998; 84: 198-206.
34. AZUMA M, MOTEGI K, AOTA K, HAYASHI Y, SATO M: Role of cytokines in the destruction of acinar structure in Sjögren's syndrome salivary glands. Lab Invest 1997; 77: 269-80.
35. WILLEKE P, SCHOTTE H, SCHLUTER B, ERREN M, BECKER H, DYONG A: Interleukin 1 beta and tumour necrosis factor alpha secreting cells are increased in the peripheral blood of patients with primary Sjögren's syndrome. Ann Rheum Dis 2003; 62: 359-62.
36. GARCIA-CARRASCO M, FONT J, FILELLA X et al.: Circulating levels of Th1/Th2 cytokines in patients with primary Sjögren's syndrome: correlation with clinical and immunological features. Clin Exp Rheumatol 2001; 19: 411-5.
37. KOLKOWSKI EC, RETH P, PELUSA F et al.: Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome. J Autoimmun 1999; 13: 155-62.
38. PERTOVAARA M, HULKKONEN J, ANTONEN J et al.: Polymorphism of the tumour necrosis factor-alpha gene at position -308 and renal manifestations of primary Sjögren's syndrome. Rheumatology 2004; 43: 106-7.
39. GUGGENBUHL P, VEILLARD E, QUELVENEC E et al.: Analysis of TNF alpha microsatel-lites in 35 patients with primary Sjögren's syndrome. Joint Bone Spine 2000; 67: 290-5.
40. GOTTENBERG JE, BUSSON M, LOISEAU P et al.: Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjogren's syndrome. Arthritis Rheum 2004; 50: 570-80.
41. BAYLEY JP, OTTENHOFF TH, VERWEIJ CL: Is there a future for TNF promoter polymorphisms? Genes Immun 2004; 5: 1-15.
42. ANAYA JM, SHOENFELD Y, CORREA PA, GARCÍA-CARRASCO M, CERVERA R (Eds.): Autoinmunidad y Enfermedad Autoinmune. Medellin, Corporación para Investigaciones Biológicas, 2005.